United States · Who invested in Corus Pharma?
Corus Pharma's investors include OrbiMed, JP Morgan, Novo Holdings A/S, Burrill & Company and Anthem Venture Partners, and 12 more on record.
United States · Series C startup
Who invested in Corus Pharma
One round we have observed, with the 17 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2004, from 1 source
- Latest round
- Series C, $60MApr 2004
- Investors
- 17
The rounds
- Apr 2004Series C$60M
OrbiMed
JP Morgan- Novo Holdings A/S
Burrill & Company
Anthem Venture Partners- Hambrecht & Quist Capital Management
- SunAmerica Ventures
- MDS Capital
WestRiver Group
Integra Ventures- RBC Capital Markets
- Bear Stearns Health Innoventures L.P
Cascade Investment- MPM BioEquities
- Pacific Rim Ventures LLC
Carnegie- Washington State University Research Foundation
From a historical funding record
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
Novo Holdings A/SGrowth equity1round
Hambrecht & Quist Capital ManagementGrowth equity1round
SunAmerica VenturesVC firm1round
MDS CapitalGrowth equity1round
RBC Capital MarketsInvestment firm1round
Bear Stearns Health Innoventures L.PVC firm1round
MPM BioEquitiesGrowth equity1round
Pacific Rim Ventures LLCGrowth equity1round
Washington State University Research Foundationno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Corus Pharma
How much has Corus Pharma raised?
Corus Pharma has raised $60M across 1 round since 2004.
When did Corus Pharma last raise?
Corus Pharma's most recent round was a Series C of $60M in Apr 2004.
What was Corus Pharma's biggest round?
Its most recent round, $60M in Apr 2004, is also its largest on record.
Who backed Corus Pharma first?
Corus Pharma's first round on record, in Apr 2004, was backed by OrbiMed, JP Morgan and Novo Holdings A/S and 14 others.
What stage is Corus Pharma at?
Corus Pharma's latest named round is a Series C, in Apr 2004.
Where is Corus Pharma based?
Corus Pharma is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.